Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells

被引:50
作者
Remstein, ED
Hanson, CA
Kyle, RA
Hodnefield, JM
Kurtin, PJ
机构
[1] Mayo Clin, Div Anat Pathol, Dept Lab Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA
关键词
D O I
10.1053/sonc.2003.50073
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We studied the clinical, morphologic, and immunophenotypic features of 26 Waldenstrom's macroglobulinemia (WM) cases, each with an IgM spike of ≥3.0 g/dL. The neoplastic cells were consistently composed of a spectrum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells. Bone marrow (BM) involvement ranged from 10% to 90%, showed four histologic patterns (nodular [75%], interstitial [75%], paratrabecular [42%], and diffuse [4%]), two histologic subtypes (lymphoplasmacytic [87%] and lymphoplasmacytoid [13%]), and several cytologic variants (monocytoid [n = 2], signet-ring cell [n = 2], and hairy cell leukemia-like [n = 1]). By flow cytometry (FC), all cases expressed monoclonal surface immunoglobulin, CD 19, and CD20. Most cases (58%) lacked expression of CD5, CD10, and CD23. However, variants such as CD5+CD10-CD23- (n = 3), CD5+CD10-CD23+ (n = 1), and CD5-CD10+CD23+/-(n = 2) were seen. At last follow-up, 18 of 26 patients were alive (median survival, 94 months). Causes of death included WM (n = 1), large cell lymphoma (n = 1), acute myeloid leukemia (likely therapy-related [n =2]), and nonhematologic/unknown. When individual WM cases are compared, apparent morphologic diversity is suggested. However, every WM case is comprised of cells along a morphologic continuum from small lymphocytes to plasma cells, delineating a uniform, consistent pathology. As WM shows immunophenotypic heterogeneity, morphology must be the cornerstone of the diagnosis. © 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:182 / 186
页数:5
相关论文
共 23 条
[1]  
Andriko JAW, 1997, CANCER, V80, P1926, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1926::AID-CNCR9>3.0.CO
[2]  
2-L
[3]  
BARTL R, 1983, SCAND J HAEMATOL, V31, P359
[4]  
Caenazzo A, 1997, HAEMATOLOGICA, V82, P122
[5]   CLEAR CELL MYELOMA [J].
CHEN, KTK ;
MA, CK ;
NELSON, JW ;
PADMANABHAN, A ;
BRITTIN, GM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1985, 9 (02) :149-154
[6]   Waldenstrom's macroglobulinemia is a biological syndrome which may occur during the evolution of different types of low grade B cell lymphoma [J].
Diebold, J ;
Molina, T ;
Tissier, F ;
le Tourneau, A ;
Audouin, J .
LEUKEMIA, 1999, 13 (10) :1637-+
[7]   MULTIPLE-MYELOMA SHOWING SIGNET-RING CELL-CHANGE [J].
EYDEN, BP ;
BANERJEE, SS .
HISTOPATHOLOGY, 1990, 17 (02) :170-172
[8]   PROGNOSTIC FACTORS IN WALDENSTROM MACROGLOBULINEMIA - A REPORT OF 167 CASES [J].
FACON, T ;
BROUILLARD, M ;
DUHAMEL, A ;
MOREL, P ;
SIMON, M ;
JOUET, JP ;
BAUTERS, F ;
FENAUX, P .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1553-1558
[9]   STUDY OF PROGNOSIS IN WALDENSTROMS MACROGLOBULINEMIA - A PROPOSAL FOR A SIMPLE BINARY CLASSIFICATION WITH CLINICAL AND INVESTIGATIONAL UTILITY [J].
GOBBI, PG ;
BETTINI, R ;
MONTECUCCO, C ;
CAVANNA, L ;
MORANDI, S ;
PIERESCA, C ;
MERLINI, G ;
BERTOLONI, D ;
GRIGNANI, G ;
POZZETTI, U ;
CAPORALI, R ;
ASCARI, E .
BLOOD, 1994, 83 (10) :2939-2945
[10]   Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma [J].
Hanson, CA ;
Kurtin, PJ ;
Katzmann, JA ;
Hoyer, JD ;
Li, CY ;
Hodnefield, JM ;
Meyers, CH ;
Habermann, TM ;
Witzig, TE .
BLOOD, 1999, 94 (11) :3889-3896